Characterising Frailty Using Magnetic Resonance Imaging
Launched by UNIVERSITY OF NOTTINGHAM · Oct 28, 2020
Trial Information
Current as of May 24, 2025
Unknown status
Keywords
ClinConnect Summary
The study will recruit females aged over 65 years (n=51), from those attending hospital clinics for older people at both campuses of Nottingham University Hospitals National Health Service (NHS) Trust. A member of the clinical care team working within the clinic will identify potential participants who are 'frail', 'mildly frail/vulnerable' and 'non-frail' using the Clinical Frailty Scale (measured as part of routine care), and the electronic Frailty Index. Clinic staff will make the initial approach to patients about the study and if the individual is interested in taking part, clinic staf...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Females aged over 65 years of age attending Nottingham University Hospitals NHS Trust 'falls and bone health' and general geriatric clinics;
- • Able to provide informed consent;
- • Once 17 participants have been recruited to any of the three study groups (non-frail, pre-frail, frail) the study will be restricted to people in the remaining groups only;
- • Good understanding of written and spoken English.
- Exclusion Criteria:
- • Metal within the body which could be affected by MRI;
- • Any other contraindications for MRI scan (e.g. brain aneurysm clips, permanent pacemaker);
- • Over 190.5 cm in height
- • Inability to lie on back within the MRI scanner
- • Mobility limitations which would prevent the individual transferring onto equipment
- • Unable to speak or understand English;
- • In receipt of end of life care;
- • Lacking the mental capacity to understand the requirements of study participation and provide consent.
About University Of Nottingham
The University of Nottingham is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university harnesses cutting-edge research and expert faculty to address pressing medical challenges. Through its dedicated clinical trials unit, the University of Nottingham conducts rigorous studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. The institution prioritizes ethical practices and participant safety, ensuring that all trials are designed to uphold the highest standards of scientific integrity and regulatory compliance.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nottingham, Nottinghamshire, United Kingdom
Patients applied
Trial Officials
Joseph Taylor, PhD student
Principal Investigator
University of Nottingham
Tahir Masud, Professor
Principal Investigator
Nottingham University Hospitals NHS Trust
Paul Greenhaff, Professor
Principal Investigator
University of Nottingham
Susan Francis, Professor
Principal Investigator
University of Nottingham
John Gladman, Professor
Study Chair
University of Nottingham
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials